Waltraud Kreutz-Gers

The Institut für Verbundwerkstoffe GmbH (IVW) is a non-profit research institution located in Kaiserslautern, Germany. IVW researches the basis for future applications of composite materials, such as for the mobility of the future, energy, climate, and the environment. The German company examines new materials, construction methods, and manufacturing processes and tailors them to the respective requirements. The private company's research deals with the big challenges of our time, such as the energy transition. The company was founded in 1990, and the CEO is Ulf Breuer. IVW transfers newly acquired knowledge into science, teaching, the interested public, and industrial application.

reBOOST Management GmbH engages in the acquisition, management, and sale of firms. It also offers management and consulting services. The company was founded on August 23, 2018 and is headquartered in Mainz, Germany.

Medine GmbH engages in the holding of participating interests in firms. It also manages its own assets and provides business consulting services. The company was founded on August 15, 2008 and is headquartered in Mainz, Germany.

Part of BioNTech SE, BioNTech Delivery Technologies GmbH is a German company that engages in research and development of immunotherapies. The company is based in Halle, Germany. The CEOs of the company are Ugur Sahin, Sierk Poetting.

The Deutsches Forschungszentrum für Künstliche Intelligenz GmbH engages in the research and development of software technology based on artificial intelligence. It develops product functions, prototypes and patentable solutions in the field of information and communication technology. The company was founded in 1988 and is headquartered in Kaiserslautern, Germany.

Part of Universitätsklinikum Freiburg, Universitäts-Herzzentrum Freiburg-Bad Krozingen GmbH is a cutting-edge medical center that provides the latest medical standards to its patients. The center is located in Bad Krozingen, Germany, and is involved in research to gain new insights into the causes and mechanisms of diseases of the cardiovascular system. The center also researches the influences of the environment and lifestyle on the development of these diseases and looks for ways to prevent them. Despite all scientific and methodical demands, the patients and their needs are the center's priority. The center has an interdisciplinary team that cares for around 22,000 inpatients every year. The German company was founded in 2012, and the CEOs are Frederik Wenz and Anja Simon. Universitäts-Herzzentrum Freiburg-Bad Krozingen was acquired by Universitätsklinikum Freiburg on July 09, 2020.